← Eichor
Study identifier: NCT07574333 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in Patients With Type 2 Diabetes Including Elderly

Condition: Type 2 Diabetes Mellitus (T2DM) · Hyperglycemia · Metabolic Syndrome  ·  Sponsor: National Medical Research Center for Therapy and Preventive Medicine

PhaseNA
Planned participants250
Who can joinAll sexes, 50 Years to 74 Years
Healthy volunteersNo

About this study

This is a single-center randomized controlled trial evaluating the efficacy and safety of short (3 days) versus long (10 days) courses of intermittent hypoxic-hyperoxic training (IHHT) in patients with type 2 diabetes mellitus aged 50-74 years. Participants will be randomized into three groups: 3-day IHHT course (n≥100), 10-day IHHT course (n≥100), or control group receiving gas mixture with constant O2 21% for 10 days (n≥50). The primary outcomes are fasting glucose levels and HbA1c. Secondary outcomes include cardiovascular parameters, quality of life, cognitive function, and biological age.

This description comes directly from the study's public registry record.

Talk to the study team

Mikhail G Chashchin, PhD  ·  +79774331118  ·  dr.chaschin@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

National Medical Research Center for Therapy and Preventive MedicineMoscow, RussiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07574333